---
title: Right Value Drug Stores LLC Issues Recall for Testosterone Cypionate
canonical: https://federalfeed.com/right-value-drug-stores-llc-issues-recall-for-testosterone-cypionate/
published: '2026-11-02T18:21:26-05:00'
updated: '2026-11-02T18:21:26-05:00'
author: FederalFeed Staff
section: Medicine & Device Recalls
tags:
- FDA
source: Food and Drug Administration
source_url: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=100109
publisher: FederalFeed
attribution: Copyright FederalFeed. Quote with credit to FederalFeed and a link to the canonical URL above.
---

# Right Value Drug Stores LLC Issues Recall for Testosterone Cypionate

Right Value Drug Stores LLC announced a recall of Testosterone Cypionate, 200 mg/mL, on October 9, 2026. The recall, classified as Class II, affects products packaged in 5 mL and 30 mL vials and is due to a lack of sterility assurance.

The recall is ongoing and applies to products distributed nationwide in the USA. Details of the recall can be found in the FDA's weekly enforcement report.

---

### Press Release: Food and Drug Administration

*Published October 28, 2026. Reproduced in full from the [Food and Drug Administration](https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=100109).*

#### Right Value Drug Stores LLC drug recall

- Recalling company: Right Value Drug Stores LLC
- Classification: Class II (may cause temporary or reversible health problems)
- Recall numbers: D-0070-2027
- Status: Ongoing
- Distribution: Nationwide in the USA.
- Recall started: October 9, 2026

#### What was recalled

Testosterone Cypionate, 200 mg/mL, packaged in a) 5 mL vials (NDC 73271-1225-1) and b) 30 m vials ( NDC 73271-1226-2) This Is A Compounded Dug, Intramuscular Use, Office Use Only, 8400 Esters Blvd, STE 190, Irving, TX 75063.

#### Why

Lack of sterility assurance.

This drug recall appears in the FDA's weekly enforcement report. Details: [FDA recall event 100109](https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=100109).

Source: [Food and Drug Administration](https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=100109)